GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eone Diagnomics Genome Center Co Ltd (XKRX:245620) » Definitions » Revenue

Eone Diagnomics Genome Center Co (XKRX:245620) Revenue : ₩73,966 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Eone Diagnomics Genome Center Co Revenue?

Eone Diagnomics Genome Center Co's revenue for the three months ended in Mar. 2024 was ₩9,708 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩73,966 Mil. Eone Diagnomics Genome Center Co's Revenue per Share for the three months ended in Mar. 2024 was ₩82.31. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩736.78.

Warning Sign:

Eone Diagnomics Genome Center Co Ltd revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Eone Diagnomics Genome Center Co was -22.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 30.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 26.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 9 years, Eone Diagnomics Genome Center Co's highest 3-Year average Revenue per Share Growth Rate was 201.40% per year. The lowest was 13.50% per year. And the median was 46.35% per year.


Eone Diagnomics Genome Center Co Revenue Historical Data

The historical data trend for Eone Diagnomics Genome Center Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eone Diagnomics Genome Center Co Revenue Chart

Eone Diagnomics Genome Center Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only 56,721.87 92,541.21 89,282.11 94,243.69 88,456.75

Eone Diagnomics Genome Center Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24,198.52 27,647.16 21,636.22 14,974.84 9,707.66

Competitive Comparison of Eone Diagnomics Genome Center Co's Revenue

For the Diagnostics & Research subindustry, Eone Diagnomics Genome Center Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eone Diagnomics Genome Center Co's Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eone Diagnomics Genome Center Co's Revenue distribution charts can be found below:

* The bar in red indicates where Eone Diagnomics Genome Center Co's Revenue falls into.



Eone Diagnomics Genome Center Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩73,966 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eone Diagnomics Genome Center Co  (XKRX:245620) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Eone Diagnomics Genome Center Co Revenue Related Terms

Thank you for viewing the detailed overview of Eone Diagnomics Genome Center Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Eone Diagnomics Genome Center Co (XKRX:245620) Business Description

Traded in Other Exchanges
N/A
Address
4th Floor, 291 Harmony-ro, Yeonsu-Gu, Incheon, KOR, 22014
Eeone Diagnomics Genome Center Co Ltd is engaged in developing and personalizing medicine based on Next Generation Sequencing technology and cutting edge genomics analysis. The company provides various personal genome sequencing and bioinformatics solutions to biomedical researchers, physicians and individuals seeking to understand the genetic influence of personal health and disease.

Eone Diagnomics Genome Center Co (XKRX:245620) Headlines

No Headlines